Anti-Human CD248 Recombinant Antibody
-
产品编号
YR1332
-
别名
科研级 Ontuxizumab ( 昂妥昔珠单抗 ), Anti-CD248 Recombinant Antibody, Research Grade Ontuxizumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Ontuxizumab ( 昂妥昔珠单抗 ), Anti-CD248 Recombinant Antibody, Research Grade Ontuxizumab |
| Catalog Number | YR1332 |
| Molecular Name | Ontuxizumab |
| Host | Mouse |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | IgG1 Kappa |
| Formulation | PBS, pH7.5 |
| Background | Ontuxizumab is a humanized rabbit monoclonal antibody designed for the treatment of cancer. It binds to endosialin (TEM1 or CD248). Phase I trials are complete and the drug was granted orphan drug status by the FDA for sarcoma. It is currently in phase II trials for melanoma, colorectal cancer, sarcoma, and lymphoma. This drug was developed by Morphotek and Ludwig Institute for Cancer Research. |
| CAS Number | 946415-62-9 |
| Application | Neut, ELISA, IF, IP, FuncS, FCM, ICC |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | CD248[Homo sapiens] |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5号楼
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
